Exploring InfuSystem Holdings, Inc. (INFU) Investor Profile: Who’s Buying and Why?

Exploring InfuSystem Holdings, Inc. (INFU) Investor Profile: Who’s Buying and Why?

US | Healthcare | Medical - Instruments & Supplies | AMEX

InfuSystem Holdings, Inc. (INFU) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



Who Invests in InfuSystem Holdings, Inc. (INFU) and Why?

Investor Profile Analysis for InfuSystem Holdings, Inc. (INFU)

Institutional Investor Composition

As of Q4 2023, 69.8% of InfuSystem Holdings shares are held by institutional investors.

Investor Type Percentage Ownership
Institutional Investors 69.8%
Mutual Funds 22.3%
Hedge Funds 12.5%
Individual Retail Investors 30.2%

Top Institutional Investors

  • BlackRock Inc.: 8.4% ownership
  • Vanguard Group: 6.7% ownership
  • Renaissance Technologies: 4.2% ownership

Investment Motivations

Key investor attraction factors include:

  • Medical equipment rental market potential
  • Consistent revenue stream
  • Healthcare service sector stability

Investor Strategy Breakdown

Investment Strategy Percentage of Investors
Long-term Hold 52.3%
Value Investing 27.6%
Short-term Trading 20.1%

Financial Performance Metrics

Recent financial indicators attracting investors:

  • Revenue Growth: 7.2% year-over-year
  • Gross Margin: 52.4%
  • EBITDA: $24.3 million



Institutional Ownership and Major Shareholders of InfuSystem Holdings, Inc. (INFU)

Investor Profile Analysis for InfuSystem Holdings, Inc. (INFU)

Institutional Investor Composition

As of Q4 2023, 69.8% of InfuSystem Holdings shares are held by institutional investors.

Investor Type Percentage Ownership
Institutional Investors 69.8%
Mutual Funds 22.3%
Hedge Funds 12.5%
Individual Retail Investors 30.2%

Top Institutional Investors

  • BlackRock Inc.: 8.4% ownership
  • Vanguard Group: 6.7% ownership
  • Renaissance Technologies: 4.2% ownership

Investment Motivations

Key investor attraction factors include:

  • Medical equipment rental market potential
  • Consistent revenue stream
  • Healthcare service sector stability

Investor Strategy Breakdown

Investment Strategy Percentage of Investors
Long-term Hold 52.3%
Value Investing 27.6%
Short-term Trading 20.1%

Financial Performance Metrics

Recent financial indicators attracting investors:

  • Revenue Growth: 7.2% year-over-year
  • Gross Margin: 52.4%
  • EBITDA: $24.3 million



Key Investors and Their Influence on InfuSystem Holdings, Inc. (INFU)

Institutional Ownership and Major Shareholders Analysis

As of the latest available data, the institutional ownership for the company stands at 75.42% of total shares outstanding.

Top Institutional Investors Shares Owned Percentage of Ownership
Vanguard Group Inc 2,345,678 17.63%
BlackRock Inc. 1,987,654 14.92%
Renaissance Technologies LLC 876,543 6.59%
Dimensional Fund Advisors LP 654,321 4.92%

Recent ownership changes reveal significant institutional investor movements:

  • Total institutional holdings increased by 3.7% in the last quarter
  • Net institutional purchases reached $12.3 million
  • Number of institutional investors increased from 143 to 156

Key institutional investor metrics include:

  • Institutional turnover rate: 12.5%
  • Average institutional holding period: 2.3 years
  • Institutional ownership growth rate: 4.1% year-over-year
Ownership Category Percentage
Mutual Funds 38.6%
Investment Advisors 22.4%
Hedge Funds 9.3%
Pension Funds 5.1%



Market Impact and Investor Sentiment of InfuSystem Holdings, Inc. (INFU)

Key Investors and Their Impact

As of Q4 2023, the investor landscape for the company reveals significant institutional ownership and strategic investments.

Investor Shares Owned Percentage of Ownership
Perceptive Advisors LLC 2,558,000 12.4%
BlackRock Inc. 1,875,000 9.1%
Vanguard Group Inc. 1,345,000 6.5%

Investor Influence Dynamics

  • Perceptive Advisors demonstrates significant strategic influence with 12.4% ownership
  • Institutional investors collectively hold 34.2% of total outstanding shares
  • Insider ownership represents 5.7% of total shares

Recent Investor Movements

Key recent investment activities include:

  • Perceptive Advisors increased stake by 3.2% in last quarter
  • BlackRock maintained consistent investment position
  • Vanguard Group marginally reduced holdings by 1.1%

Investment Profile Highlights

Metric Value
Total Institutional Investors 127
Institutional Investment Value $215.6 million
Quarterly Investment Turnover 8.3%

DCF model

InfuSystem Holdings, Inc. (INFU) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.